Longevity Growth Investors & VC Firms
80 firms in this list, with a median first check of $1M. 26 of them lead rounds. Generated from verified public data and updated continuously.
Type One Ventures
Los AngelesPre-Seed–Late Stage$100K – $5M
28 people
JAZZ Venture Partners
San FranciscoSeed–Growth$100K – $20M
16 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Growth
29 people
Lumira Ventures
TorontoSeed–Growth$1M – $10M
17 people
Ziegler Link-age Funds
ChicagoGrowth
40 people
Hiro Capital
LondonSeries A–Late Stage
26 people
Lauder Partners
Los AltosSeed–Growth
1 person
K2 HealthVentures
BostonGrowth–Late Stage
22 people
Civilization Ventures Management, Llc
TiburonPre-Seed–Growth$1M – $10M
4 people
MVM Life Science Partners
LondonSeed–Growth$20M – $100M
20 people
Elad Gil
San FranciscoSeed–Growth$100K – $10M
1 person
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
22 people
Northstar Ventures
Newcastle upon TynePre-Seed–Late Stage$38.1K – $1.3M
17 people
ECP Growth
GreenwichGrowth
15 people
Pontifax Venture Capital
HerzeliyaSeed–Late Stage
7 people
Merck Global Health Innovation Fund
RahwaySeed–Growth$10M
10 people
Hadean Ventures
OsloSeed–Growth
21 people
HBM Healthcare Investments
ZugGrowth
8 people
DCVC Bio
Palo AltoSeed–Growth
14 people
Nordstar
LondonGrowth
12 people
Sciety
StockholmSeed–Growth
21 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
16 people
Related lists
Growth Investors & VC Firms (4301)Growth Investors & VC Firms in North America (2155)Growth Investors & VC Firms in United States (1870)Growth Investors & VC Firms in Europe (1648)Growth Investors & VC Firms in Global (1397)Healthtech Growth Investors & VC Firms (1282)Growth Investors & VC Firms in Asia-Pacific (1264)Enterprise Software Growth Investors & VC Firms (1211)SaaS Growth Investors & VC Firms (1192)Fintech Growth Investors & VC Firms (1183)
Data sourced from public filings and firms' own websites — see our methodology.






































































































